Related Experiment Video
Updated: Jan 21, 2026

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
A novel hydrazide compound exerts anti-metastatic effect against breast cancer
Soudeh Dehghani1, Zahra Kooshafar1, Ali Almasirad2
1Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran.
Background:
There are currently a number of barriers hindering the successful treatment of breast cancer, including the metastatic spread of cancer cells. In looking for new anticancer agents, we reported two novel hydrazide derivatives with anti-cancer activity in human breast cancer cells. The current study aims to explore the therapeutic potential of the most effective one, N'-((5-nitrothiophen-2-yl)methylene)-2-(phenylthio)benzohydrazide (compound B), on metastatic breast cancer, which is resistant to available chemotherapeutics.
Methods:
4T1 mammary carcinoma cells were inoculated into the fat pad mammary of 5-7-week-old female BALB/c mice and then the effective compound was intraperitoneally administered for 4 weeks. Proliferation index and angiogenesis in tumor and lung tissues were examined with immunohistochemistry. In vitro assessments were also carried out to evaluate the effect of the compound on invasion of MDA-MB-231 cells.
Results:
Our results demonstrated that this effective derivative significantly inhibited invasion of MDA-MB-231 cells in vitro as shown by Matrigel assay and quantitative real-time method for MMP-9 expression after 48 h of treatment. Daily administration of the compound suppressed the growth of primary tumor and its metastasis to lung, which was confirmed by H&E experiment at a dose of 1 mg/kg in a well-known metastatic model of 4T1 breast cancer in syngeneic BALB/c mice. These outcomes were supported by the immunohistochemical examinations of the tumor and lung tissues of mice. Tumors and lungs in mice treated with the effective compound showed a reduced proliferation index and a smaller microvessel density compared to the control.
Conclusion:
This study highlights an anti-metastatic role for a novel hydrazide derivative in both in vitro and in vivo models of breast cancer.
Insights
A novel hydrazide derivative, compound B, effectively inhibits breast cancer metastasis in vitro and in vivo. This compound shows significant potential as an anti-metastatic agent for drug-resistant breast cancer.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Metastatic breast cancer presents significant treatment challenges due to resistance to existing therapies.
- Novel anticancer agents are crucial for overcoming treatment barriers, particularly cancer cell spread.
- Two hydrazide derivatives demonstrated anti-cancer activity in breast cancer cells, prompting further investigation.
Purpose of the Study:
- To evaluate the therapeutic potential of N'-((5-nitrothiophen-2-yl)methylene)-2-(phenylthio)benzohydrazide (compound B) against metastatic breast cancer.
- To assess the anti-metastatic effects of compound B in both in vitro and in vivo models.
- To explore compound B's efficacy in overcoming resistance to current chemotherapeutics.
Main Methods:
- In vitro assessment of MDA-MB-231 cell invasion using Matrigel assay and MMP-9 expression analysis.
- In vivo study involving inoculation of 4T1 mammary carcinoma cells in BALB/c mice.
- Intraperitoneal administration of compound B for 4 weeks, followed by immunohistochemistry for proliferation index and angiogenesis.
Main Results:
- Compound B significantly inhibited MDA-MB-231 cell invasion in vitro, reducing MMP-9 expression.
- Daily administration of compound B suppressed primary tumor growth and lung metastasis in a 4T1 breast cancer mouse model.
- Immunohistochemical analysis revealed reduced proliferation and microvessel density in tumors and lungs of treated mice.
Conclusions:
- Compound B exhibits significant anti-metastatic activity in preclinical breast cancer models.
- The novel hydrazide derivative demonstrates potential as a therapeutic agent for metastatic breast cancer.
- Further research into compound B could lead to new treatments for drug-resistant metastatic breast cancer.
More Related Videos
06:52Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Published on: November 5, 2021
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Molecules and Compounds
Organic Compounds
Elements and Compounds
Elements
Elements are classified as atomic or molecular based on the nature of their basic units. They are unique forms of matter with specific chemical and physical properties that cannot break down into smaller substances by ordinary chemical reactions. There...
Solubility of Ionic Compounds
Classification of Elements and Compounds
Compounds are pure substances composed of two or more elements in fixed, definite proportions. Compounds are classified as ionic or molecular (covalent) based on the bonds...
Coordination Compounds and Nomenclature